AC
Avoro Capital Advisors LLC disclosed a 5.5% stake in FTH
Avoro Capital Advisors LLC reported owning 5.5% of Faeth Therapeutics, Inc. (FTH) (1,410,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G